J Mark Christensen Selected Research

Pharmaceutical Preparations

1/2009

Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Mark Christensen Research Topics

Disease

2	Weight Gain 01/2012 - 04/2010
2	Aspergillosis 06/2010 - 06/2010
2	Ulcerative Colitis 04/2010 - 01/2009
1	Sudden Infant Death (SID) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 04/2010
1	Wounds and Injuries (Trauma) 10/2008
1	Marijuana Use 01/2008

Drug/Important Bio-Agent (IBA)

3	Mesalamine (Mesalazine)FDA LinkGeneric 01/2012 - 01/2009
2	TabletsIBA 01/2012 - 04/2010
2	Terbinafine (Lamisil)FDA LinkGeneric 06/2010 - 06/2010
1	ethyl celluloseIBA 01/2012
1	GelatinIBA 04/2010
1	sodium starch glycolateIBA 04/2010
1	methylmethacrylate-methacrylic acid copolymerIBA 04/2010
1	stearic acid (magnesium stearate)FDA LinkGeneric 04/2010
1	Pharmaceutical PreparationsIBA 01/2009
1	Volatile Oils (Essential Oils)IBA 10/2008
1	Benzethonium (Magic, Formula)IBA 10/2008
1	Gramicidin (Gramicidin A)FDA LinkGeneric 10/2008
1	Neomycin FDA LinkGeneric 10/2008
1	Polymyxin B (Aerosporin)FDA LinkGeneric 10/2008
1	11- nor- delta(9)- tetrahydrocannabinol- 9- carboxylic acidIBA 01/2008
1	Dronabinol (THC)FDA LinkGeneric 01/2008

Therapy/Procedure

1	Oral Administration 01/2021